PMC10247956_01
Longitudinal safety data from JAKi initiation (baseline) illustrated by (A) hemoglobin concentration, (B) leukocyte count, and (C) platelet count. *p <0.05, **p < 0.01.
fimmu-14-1187584-g002.jpg
PMC10247956_01_fimmu-14-1187584-g002.jpg
f2
Only minor effects were observed on blood cell counts over time ( Figures 2A-C ).
PMC10247956_02
PMC10247956_03